Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Clarify how the wash-sale rule applies to ETFs, including practical timing, replacement restrictions, and compliant planning.
9,454 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Nasdaq welcomes the 21Shares Canton Network ETF, the latest milestone in the ongoing crypto ETF surge. The fund aims ...
High-income investors face a tax cliff with JEPI: the 8% distribution yield is largely ordinary income, trimming real...
Investors are looking a decade out at XRP, weighing regulatory clarity, RippleNet expansion, and new use cases as the...
The bitcoin’s drop toward $72,000 intensified as U.S.-Iran tensions resurfaced, prompting a risk-off move across cryp...
Morgan Stanley and Galaxy Digital roll out a pilot allowing eligible clients to lend crypto in return for in-kind cry...
Two energy infrastructure ETFs are under the lens as crude markets stay volatile. EMLP and ENFR continue payouts, but...
Perplexity AI unveils a multi-scenario Solana forecast through 2026, highlighting faster networks and rising institut...
2023 stock market trends for beginners revealed a mix of AI-driven gains and cautious optimism. This guide translates...
Regulatory clarity is heating up this summer. As Congress moves forward with the Clarity Act, Ethereum could emerge a...
The iShares Semiconductor ETF surged in the first half of 2026, powered by AI infrastructure demand and a rebound in ...
Thai and Taiwanese AI stock funds are gaining traction as Korea’s AI boom extends across Asia. This report examines w...